Application of optical biosensors in small-molecule screening activities

Sensors

Volumn 12, Issue 4, 2012, Pages 4311-4323

  Geschwindner, Stefan ^a   Carlsson, Johan F ^a   Knecht, Wolfgang ^a  

^a ASTRAZENECA R AND D   (Sweden)

Author keywords

Biosensor; Drug discovery; Fragment; Ligand; Optical waveguide grating; Screening; Surface plasmon resonance

Indexed keywords

GENETIC PROCEDURES; OPTICS; REVIEW; SURFACE PLASMON RESONANCE;

BIOSENSING TECHNIQUES; OPTICS AND PHOTONICS; SURFACE PLASMON RESONANCE;

EID: 84860124363     PISSN: 14248220     EISSN: None     Source Type: Journal    
DOI: 10.3390/s120404311     Document Type: Review

References (24)

1. Holdgate, G.A.; Anderson, M.; Edfeldt, F.; Geschwindner, S. Affinity-based, biophysical methods to detect and analyze ligand binding to recombinant proteins: Matching high information content with high throughput. J. Struct. Biol. 2010, 172, 142-157.
2. Ladbury, J.E.; Klebe, G.; Freire, E. Adding calorimetric data to decision making in lead discovery: A hot tip. Nat. Rev. Drug Discov. 2010, 9, 23-27.
3. Holdgate, G.A.; Gill, A.L. Kinetic efficiency: The missing metric for enhancing compound quality? Drug Discov. Today 2011, 16, 910-913.
4. Swinney, D.C. The role of binding kinetics in therapeutically useful drug action. Curr. Opin. Drug Discov. Devel. 2009, 12, 31-39.
5. Huber, W. A new strategy for improved secondary screening and lead optimization using high-resolution SPR characterization of compound-target interactions. J. Mol. Recog. 2005, 18, 273-281.
6. Danielson, U.H. Fragment library screening and lead characterization using SPR biosensors. Curr. Top. Med. Chem. 2009, 9, 1725-1735.
7. Giannetti, A.M. From experimental design to validated hits a comprehensive walk-through of fragment lead identification using surface plasmon resonance. Methods Enzymol. 2011, 493, 169-218.
8. Fang, Y.; Ferrie, A.M.; Fontaine, N.H.; Mauro, J.; Balakrishnan, J. Resonant waveguide grating biosensor for living cell sensing. Biophys. J. 2006, 91, 1925-1940.
9. Cunningham, B.T.; Li, P.; Schulz, S.; Lin, B.; Baird, C.; Gerstenmaier, J.; Genick, C.; Wang, F.; Fine, E.; Laing, L. Label-free assays on the BIND system. J. Biomol. Screen. 2004, 9, 481-490.
10. Dodgson, K.; Gedge, L.; Murray, D.C.; Coldwell, M. A 100K well screen for a muscarinic receptor using the epic label-free system-A reflection on the benefits of the label-free approach to screening seven-transmembrane receptors. J. Recept. Signal Transduct. Res. 2009, 29, 163-172.
11. O'Shannessy, D.J.; Brigham-Burke, M.; Peck, K. Immobilization chemistries suitable for use in the BIAcore surface plasmon resonance detector. Anal. Biochem. 1992, 205, 132-136.
12. Congreve, M.; Rich, R.L.; Myszka, D.G.; Figaroa, F.; Siegal, G.; Marshall, F.H. Fragment screening of stabilized G-protein-coupled receptors using biophysical methods. Methods Enzymol. 2011, 493, 115-136.
13. Rich, R.L.; Errey, J.; Marshall, F.; Myszka, D.G. Biacore analysis with stabilized G-protein-coupled receptors. Anal. Biochem. 2011, 409, 267-272.
14. Giannetti, A.M.; Koch, B.D.; Browner, M.F. Surface plasmon resonance based assay for the detection and characterization of promiscuous inhibitors. J. Med. Chem. 2008, 51, 574-580.
15. Dalvit, C. NMR methods in fragment screening: Theory and a comparison with other biophysical techniques. Drug Discov. Today 2009, 14, 1051-1057.
16. Hamalainen, M.D.; Zhukov, A.; Ivarsson, M.; Fex, T.; Gottfries, J.; Karlsson, R.; Bjorsne, M. Label-free primary screening and affinity ranking of fragment libraries using parallel analysis of protein panels. J. Biomol. Screen. 2008, 13, 202-209.
17. Nordstrom, H.; Gossas, T.; Hamalainen, M.; Kallblad, P.; Nystrom, S.; Wallberg, H.; Danielson, U.H. Identification of MMP-12 inhibitors by using biosensor-based screening of a fragment library. J. Med. Chem. 2008, 51, 3449-3459.
18. Karlsson, R. Real-time competitive kinetic analysis of interactions between low-molecular-weight ligands in solution and surface-immobilized receptors. Anal. Biochem. 1994, 221, 142-151.
19. Retra, K.; Geitmann, M.; Kool, J.; Smit, A.B.; de Esch, I.J.P.; Danielson, U.H.; Irth, H. Development of surface plasmon resonance biosensor assays for primary and secondary screening of acetylcholine binding protein ligands. Anal. Biochem. 2010, 407, 58-64.
20. Fong, C.C.; Lai, W.P.; Leung, Y.C.; Lo, S.C.; Wong, M.S.; Yang, M. Study of substrate-enzyme interaction between immobilized pyridoxamine and recombinant porcine pyridoxal kinase using surface plasmon resonance biosensor. Biochim. Biophys. Acta 2002, 1596, 95-107.
21. Cannon, M.J.; Myszka, D.G.; Bagnato, J.D.; Alpers, D.H.; West, F.G.; Grissom, C.B. Equilibrium and kinetic analyses of the interactions between vitamin B(12) binding proteins and cobalamins by surface plasmon resonance. Anal. Biochem. 2002, 305, 1-9.
22. Geschwindner, S.; Olsson, L.L.; Albert, J.S.; Deinum, J.; Edwards, P.D.; de Beer, T.; Folmer, R.H. Discovery of a novel warhead against beta-secretase through fragment-based lead generation. J. Med. Chem. 2007, 50, 5903-5911.
23. Edfeldt, F.N.; Folmer, R.H.; Breeze, A.L. Fragment screening to predict druggability (Ligandability) and lead discovery success. Drug Discov. Today 2011, 16, 284-287.
24. Neumann, L.; von König, K.; Ullmann, D. HTS reporter displacement assay for fragment screening and fragment evolution toward leads with optimized binding kinetics, binding selectivity, and thermodynamic signature. In Methods in Enzymology; Academic Press Inc.: San Diego, CA, USA, 2011; Chapter twelve, pp. 299-320.